J1725 — Injection, hydroxyprogesterone caproate, 1 mg
J1725 is a HCPCS Level II code for injection, hydroxyprogesterone caproate, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2017 and is not valid on new claims.
This code has been terminated
CMS terminated J1725 on December 31, 2017. It stays in the file as history — a claim you are auditing from before that date may legitimately carry it — but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.
Medicare coverage: Not payable by Medicare
Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.
The CMS record for J1725
- Long descriptor
- Injection, hydroxyprogesterone caproate, 1 mg
- Short descriptor
- Hydroxyprogesterone caproate
- Added
- January 1, 2012
- Terminated
- December 31, 2017
- BETOS
- O1E
- Pricing indicator
- 00 — Not priced by Part B
The official wording. This is what the code means.
CMS's 28-character form, which is what shows up on a remittance advice.
When CMS introduced the code.
When CMS retired it.
Berenson-Eggers Type of Service — CMS's own analytic grouping.
Service not separately priced by Part B — not covered, bundled into another service, or used by Part A only.
Codes adjacent to J1725
HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1725 is not quite right, the correct code is very often within a few positions of it.
- J1650Injection, enoxaparin sodium, 10 mg
- J1652Injection, fondaparinux sodium, 0.5 mg
- J1655Injection, tinzaparin sodium, 1000 iuterminated
- J1670Injection, tetanus immune globulin, human, up to 250 units
- J1675Injection, histrelin acetate, 10 micrograms
- J1700Injection, hydrocortisone acetate, up to 25 mg
- J1710Injection, hydrocortisone sodium phosphate, up to 50 mgterminated
- J1720Injection, hydrocortisone sodium succinate, up to 100 mg
- J1726Injection, hydroxyprogesterone caproate, (makena), 10 mg
- J1729Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
- J1730Injection, diazoxide, up to 300 mg
- J1736Injection, meloxicam (delova), 1 mg
- J1737Injection, meloxicam (azurity), 1 mg
- J1738Injection, meloxicam, 1 mg
- J1740Injection, ibandronate sodium, 1 mg
- J1741Injection, ibuprofen, 100 mg
Questions about J1725
What is HCPCS code J1725?
J1725 is a HCPCS Level II code for injection, hydroxyprogesterone caproate, 1 mg. It sits in the Drugs Administered Other Than Oral Method section.
Does Medicare cover J1725?
The CMS HCPCS file marks J1725 as "Not payable by Medicare". Medicare does not pay this code. It may still be valid for another payer, but a Medicare claim carrying it will not be reimbursed.
Is J1725 still valid?
No. J1725 was terminated on December 31, 2017 and should not be used on new claims.